ovarian cancer

Moffitt Cancer Center helped study the imaging drug, which the FDA recently approved. It draws attention to hard-to-spot tumors during surgery.

The verdict, reportedly the largest ever in such a case, was awarded to 22 women and their families who claim asbestos in the powder contributed to their ovarian cancer. The company plans an appeal.

An experimental vaccine could be on the market for ovarian-cancer patients as soon as 2022, according to the Jacksonville-based company that makes it....

When the NCAA Women's Final Four comes to town, cancer researchers benefit. Since 2009, the Kay Yow Cancer Fund has awarded a women's cancer research…